Zoledronate-Related Osteonecrosis of the Mandible
Authors:
- Vicki QuanVQVicki Quan
- Robert HendersonRHRobert Henderson
- 1 January 2008
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 33 (1) , 68-70
Abstract
We report the PET-CT appearance of Zoledronate-related osteonecrosis of the mandible in a 54-year-old woman with right breast cancer with osseous and pulmonary metastases. Her treatment included surgery, chemotherapy and Zoledronate, and external beam radiation treatment. During the course of treatment, the patient developed osteonecrosis of the jaw secondary to Zoledronate, which was biopsy-proven, for which Zoledronate was discontinued shortly after. Hybrid PET-CT was performed approximately 1 year after the discontinuation of Zoledronate. PET-CT images demonstrated diffuse, intense hypermetabolism in the mandible, consistent with documented osteonecrosis.Keywords
This publication has 11 references indexed in Scilit:
- Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposalsAmerican Journal of Otolaryngology, 2007
- Systematic Review: Bisphosphonates and Osteonecrosis of the JawsAnnals of Internal Medicine, 2006
- Osteonecrosis of the Mandible or Maxilla Associated with the use of New Generation BisphosphonatesThe Laryngoscope, 2006
- Bisphosphonate‐associated osteonecrosis of mandibular and maxillary boneCancer, 2005
- Zoledronic Acid: Past, Present and Future Roles in Cancer TreatmentFuture Oncology, 2005
- Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 casesJournal of Oral and Maxillofacial Surgery, 2004
- Bisphosphanates and Oral Cavity Avascular Bone NecrosisJournal of Clinical Oncology, 2003
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJournal of Oral and Maxillofacial Surgery, 2003
- Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption.Endocrinology, 1996
- Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.Journal of Clinical Investigation, 1993